Tamoxifen as Prophylaxis for Prevention of Gynaecomastia and Breast Pain Associated with Bicalutamide 150 mg Monotherapy in Patients with Prostate Cancer: A Randomised, Placebo-Controlled, Dose-Response Study

European Urology

Volumn 52, Issue 1, 2007, Pages 106-115

  Fradet, Yves ^a   Egerdie, Blair ^b   Andersen, Morten ^b   Tammela, Teuvo L J ^c   Nachabe, Mahmoud ^d   Armstrong, Jon ^e   Morris, Thomas ^e   Navani, Sunil ^e  

^a LAVAL UNIVERSITY   (Canada)

^b Moelv Spesialistsenter ^*  (Norway)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d HÔPITAL CHARLES LEMOYNE   (Canada)

^e ASTRAZENECA   (United Kingdom)

Author keywords

Bicalutamide; Breast pain; Gynaecomastia; Management; Nonsteroidal antiandrogen; Prophylaxis; Prostate cancer; Tamoxifen

Indexed keywords

BICALUTAMIDE; PLACEBO; PROSTATE SPECIFIC ANTIGEN; TAMOXIFEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GYNECOMASTIA; HOT FLUSH; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASTALGIA; MONOTHERAPY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANILIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTROGEN ANTAGONISTS; FOLLOW-UP STUDIES; GYNECOMASTIA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; NITRILES; PAIN; PROSTATIC NEOPLASMS; TAMOXIFEN; TOSYL COMPOUNDS; TREATMENT OUTCOME;

EID: 34249001119     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.01.031     Document Type: Article

References (22)

1. Fourcade R.-O., and McLeod D. Tolerability of antiandrogens in the treatment of prostate cancer. Urooncology 4 (2004) 5-13
2. Migliari R., Muscas G., Murru M., Verdacchi T., De Benedetto G., and De Angelis M. Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy. Arch Ital Urol Androl 71 (1999) 293-302
3. Anderson J. The role of antiandrogen monotherapy in the treatment of prostate cancer. BJU Int 91 (2003) 455-461
4. Wirth M.P., Hakenberg O.W., and Froehner M. Antiandrogens in the treatment of prostate cancer. Eur Urol 51 (2007) 306-314
5. Tyrrell C.J. Gynaecomastia: aetiology and treatment options. Prostate Cancer Prostatic Dis 2 (1999) 167-171
6. McLeod D.G., and Iversen P. Gynecomastia in patients with prostate cancer: a review of treatment options. Urology 56 (2000) 713-720
7. Fruhstorfer B.H., and Malata C.M. A systematic approach to the surgical treatment of gynaecomastia. Br J Plast Surg 56 (2003) 237-246
8. Dicker A.P. The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy. Lancet Oncol 4 (2003) 30-36
9. Saltzstein D., Sieber P., Morris T., and Gallo J. Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole. Prostate Cancer Prostatic Dis 8 (2005) 75-83
10. Di Lorenzo G., Autorino R., Perdona S., and De Placido S. Management of gynaecomastia in patients with prostate cancer: a systematic review. Lancet Oncol 6 (2005) 972-979
11. Boccardo F., Rubagotti A., Battaglia M., et al. Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol 23 (2005) 808-815
12. Perdona S., Autorino R., De Placido S., et al. Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. Lancet Oncol 6 (2005) 295-300
13. Eaton A.C., Makris A., and Makris A. Once weekly tamoxifen in the prevention of gynaecomastia and breast pain secondary to bicalutamide therapy. J Urol 171 (2004) 282 (abstract no. 1069)
14. Boccardo F., Rubagotti A., Conti G., Potenzoni D., Manganelli A., and Del Monaco D. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer. Cancer Chemother Pharmacol 56 (2005) 415-420
15. Boccardo F., Medicina D., Galmozzi F., Emionite L., and Lo C.M. 4-OH tamoxifen does not interfere with bicalutamide inhibitory effects on human prostatic cancer cells in vitro. Anticancer Res 25 (2005) 4277-4280
16. Saltzstein D., Cantwell A., Sieber P., Ross J.R., Silvay-Mandeau O., and Gallo J. Prophylactic tamoxifen significantly reduces the incidence of bicalutamide-induced gynaecomastia and breast pain. BJU Int 90 suppl 2 (2002) 120-121
17. McLeod D.G., Iversen P., See W.A., et al. Bicalutamide 150 mg plus standard care versus standard care alone for early prostate cancer. BJU Int 97 (2006) 247-254
18. Abrahamsson P.-A., Anderson J., Boccon-Gibod L., Schulman C., Studer U.E., and Wirth M. Risks and benefits of hormonal manipulation as monotherapy or adjuvant treatment in localised prostate cancer. Eur Urol 48 (2005) 900-905
19. Di Lorenzo G., Perdona S., De Placido S., et al. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy. J Urol 174 (2005) 2197-2203
20. Cantarini M.V., Macpherson M.P., Marshall A.L., Robinson A.V., and Bailey C.J. A phase I study to determine the effect of tamoxifen on the pharmacokinetics of a single 250 mg oral dose of gefitinib (IRESSA) in healthy male volunteers. Cancer Chemother Pharmacol 56 (2005) 557-562
21. Van Poppel H., Tyrrell C.J., Haustermans K., et al. Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer. Eur Urol 47 (2005) 587-592
22. Tyrrell C.J., Payne H., Tammela T.L., et al. Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. Int J Radiat Oncol Biol Phys 60 (2004) 476-483